Lemborexant is a medication used to treat insomnia. It belongs to a group of drugs called orexin receptor antagonists. It works by blocking certain chemicals in the brain that are involved in sleep and wake cycles. It is available as a tablet that is taken orally once a day, usually at bedtime. Lemborexant has been proven to help people fall asleep faster and stay asleep longer. It may also help reduce the number of nighttime awakenings.
Lemborexant, sold under the brand name Dayvigo, is a prescription medication used for the treatment of insomnia, specifically difficulty falling asleep. Here's a breakdown of its key points:
Function: Lemborexant works by targeting a specific brain receptor system involved in sleep-wake regulation. It belongs to a relatively new class of drugs called dual orexin receptor antagonists (DORAs). Orexin is a neuropeptide (signaling molecule) in the brain that promotes wakefulness. By blocking the action of orexin at its receptors, Lemborexant helps promote sleep initiation.
Applications: Lemborexant is approved for adults experiencing difficulty falling asleep associated with insomnia.
Benefits:
- Improved sleep onset: Studies suggest Lemborexant can help reduce the time it takes to fall asleep compared to placebo (inactive substance).
- Relatively fewer side effects: Compared to some older sleep medications, Lemborexant may have a lower risk of side effects like next-day drowsiness.
Important Considerations:
- Relatively new medication: Lemborexant was approved by the FDA in 2020, and long-term safety data is still being gathered.
- Not a cure: Lemborexant helps with sleep initiation but doesn't cure insomnia. Addressing underlying causes of insomnia, such as stress or sleep hygiene practices, might be necessary for long-term management.
- Potential side effects: While generally well-tolerated, some side effects can occur, including headache, dizziness, fatigue, and leg cramps.